We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+17.61%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$10.6B
AUM Growth
+$1.44B
Cap. Flow
+$92.7M
Cap. Flow %
0.88%
Top 10 Hldgs %
22.72%
Holding
2,357
New
64
Increased
127
Reduced
1,296
Closed
88

Sector Composition

Rank Sector Weight
1 Technology 20.97%
2 Healthcare 12.78%
3 Financials 12.6%
4 Consumer Discretionary 11.75%
5 Industrials 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PD icon
2301
PagerDuty
PD
$876M
-1
Closed -$14
PFIS icon
2302
Peoples Financial Services
PFIS
$714M
-3,673
Closed -$128K
PKE icon
2303
Park Aerospace
PKE
$828M
-10,569
Closed -$115K
POWL icon
2304
Powell Industries
POWL
$7.58B
-13,212
Closed -$106K
RAPT
2305
DELISTED
RAPT Therapeutics
RAPT
-668
Closed -$172K
RLGT icon
2306
Radiant Logistics
RLGT
$400M
-18,690
Closed -$96.1K
RRBI icon
2307
Red River Bancshares
RRBI
$674M
-2,422
Closed -$104K
SENEA icon
2308
Seneca Foods Class A
SENEA
$1.28B
-3,595
Closed -$128K
SGC icon
2309
Superior Group of Companies
SGC
$213M
-5,179
Closed -$120K
TVTX icon
2310
Travere Therapeutics
TVTX
$5.86B
-21,324
Closed -$394K
TXG icon
2311
10x Genomics
TXG
$7.52B
-4,918
Closed -$613K
VITL icon
2312
Vital Farms
VITL
$495M
-4,647
Closed -$188K
VLGEA icon
2313
Village Super Market
VLGEA
$627M
-4,017
Closed -$98.9K
VYGR icon
2314
Voyager Therapeutics
VYGR
$197M
-10,649
Closed -$114K
YARW
2315
Yarrow Bioscience, Inc. Common Stock
YARW
$114M
-20
Closed -$119K
WES icon
2316
Western Midstream Partners
WES
$19.9B
-293,314
Closed -$2.35M
WTTR icon
2317
Select Water Solutions
WTTR
$2.73B
-28,192
Closed -$108K
XBIT icon
2318
XBiotech
XBIT
$75M
-6,623
Closed -$126K
XERS icon
2319
Xeris Biopharma Holdings
XERS
$1.55B
-22,612
Closed -$134K
ZYXI
2320
DELISTED
Zynex
ZYXI
-8,883
Closed -$141K
ONC
2321
BeOne Medicines Ltd
ONC
$40.6B
-2,900
Closed -$831K
TAST
2322
DELISTED
Carrols Restaurant Group, Inc.
TAST
-3,958
Closed -$25.5K
SCU
2323
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
-7,985
Closed -$93.7K
MTEM
2324
DELISTED
Molecular Templates, Inc.
MTEM
-649
Closed -$106K
AGRX
2325
DELISTED
Agile Therapeutics
AGRX
-17
Closed -$102K

Similar funds

MetLife Investment Management's Q4 2020 Portfolio in Review

As of Q4 2020, MetLife Investment Management held 2,357 positions worth $10.6B, up 16% from $9.13B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

MetLife Investment Management's Q4 2020 filing shows 64 new, 127 increased, 1,296 reduced and 88 closed positions. Its largest new stake was Vanguard Short-Term Bond ETF: 4,766,514 shares worth $395M. The largest sale was Apple, an estimated $23.3M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q4 2020 buy was Vanguard Short-Term Bond ETF: 4,766,514 shares worth $395M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $23M increase.
  • MetLife Investment Management's biggest Q4 2020 reduction was Apple, cutting an estimated $23.3M.
  • MetLife Investment Management fully exited Dunkin' Brands Group, Inc. in Q4 2020, selling an estimated $3.86M.
  • MetLife Investment Management's ten largest holdings make up 23% of its $10.6B portfolio in Q4 2020.
  • MetLife Investment Management opened 64 new positions and closed 88 in Q4 2020.
  • MetLife Investment Management's portfolio value rose 16% quarter-over-quarter to $10.6B.

Based on MetLife Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.